Sale

Plaque Psoriasis Treatment Market

Global Plaque Psoriasis Treatment Market Size, Share: By Diagnosis Method: Blood Tests, Skin Prick Test, Patch Test, Biopsy, Others; By Treatment Type; By Therapy Type; By Route of Administration; By Drug Type; By Population Type; By Treatment Channel; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Plaque Psoriasis Treatment Market Outlook

The growth of the global plaque psoriasis treatment market size is being driven by the rising prevalence of the condition across the globe. The number of worldwide cases in 2023 was close to 128.64 million. The prevalence of the condition is anticipated to grow at a CAGR of 3% during the forecast period of 2024-2032, likely to reach 167.84 cases by 2032.

 

Plaque Psoriasis Treatment Market: Introduction

Psoriasis refers to a skin condition which leads to red, inflamed, raised, and itchy skin on different parts of the body. The condition has various types and plaque psoriasis is one of the most common types, affecting more than 8 million Americans every year. About 90% of psoriasis patients suffer from plaque psoriasis, making it the most prevalent type of the condition. Plaque psoriasis is an auto-immune chronic disorder in which the production of new skin cells becomes extremely fast. While the production of new skin cells normally takes place in 28-30 days, the production speeds up and the new skin cells start developing within 3 to 4 days. The replacement of old skin cells with new ones results in the production of plaques over the skin. The increased prevalence of the condition is providing significant impetus to the growth of the plaque psoriasis treatment market.

 

plaque psoriasis treatment market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Plaque psoriasis leads to severe red patches or plaques all over the skin, with thick whitish scales which are made of dead skin cells. These scales can occur throughout the body and/or on parts of the body which are mostly dehydrated, like scalp, elbows, lower back, knees, among others. Patients with severe condition also experience these scales on their face, feet, hands, legs, and even genitals, if not controlled timely. These patches are extremely problematic since it causes severe itchiness and even hurts, and the burning sensation can become intense and worse with time. It even becomes difficult for the patient to wear clothes over these patches, leading to perennial discomfort.

 

As discussed above, the most common symptoms of the condition mostly include scaly patches on the skin, which can painful and irritating. As the condition aggravates, the symptoms can intensify to crack (fissures) in skin and even bleeding in some cases.

 

The auto-immune disorder does not have a cure yet, but the available treatments are effective and can help relieve the symptoms to some extent, if followed regularly. The exact cause of the disease is not known yet, but genetic factors and immune system play a pivotal role in the development of this condition. Other diseases like Crohn's disease, fatty liver disease, diabetes, and metabolic syndrome can also lead to this skin condition.

 

Plaque Psoriasis Treatment Market- Epidemiology

Plaque psoriasis mostly happens due to genetic factors, it usually runs in the family. This skin condition can happen to anyone, irrespective of their age or sex, however, if affects some more than the others. People belonging to western regions are more vulnerable to this condition than the others.

 

The possibility of suffering from plaque psoriasis is also significantly dependent on the lifestyle of an individual. Consumption of alcohol, smoke, and other tobacco-based products can increase the chances of suffering from this disorder. Moreover, being obese can also increase a person’s vulnerability to the condition. Having depression or stress can also worsen this condition, since that mostly leads to the irregularity in the consumption of medicines and lack of self-care. The condition can also be caused due to triggers like reaction of some medicines or severe sunburn.

 

Plaque Psoriasis Treatment Market Segmentations

The market can be categorised into diagnosis method, treatment type, therapy type, route of administration, drug type, population type, treatment channel, end user, distribution channel, and major regions.

 

plaque psoriasis treatment market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Diagnosis Method

  • Blood Tests
  • Skin Prick Test
  • Patch Test
  • Biopsy 
  • Others

 

Plaque Psoriasis Treatment Market Breakup by Treatment Type

  • Biologics Drugs
    • Apremilast
    • Atanercept
    • Infliximab
    • Adalimumab
    • Ustekinumab
    • Secukinumab
    • Ixekizumab
    • Guselkumab
    • Tildrakizumab
    • Certolizumab
    • Others
  • Systemic Drugs
    • Methotrexate
    • Soriatane
    • Otezla
    • Sotyktu
    • Cyclosporin
    • Others
  • Phototherapy
    • Ultraviolet B (UVB)
  • Topical Drugs
    • Calcipotriene
    • Tazarotene
    • Calcineurin Inhibitors
    • Roflumilast
    • Salicylic Acid
    • Others
  • Others

 

Market Breakup by Therapy Type

  • Monotherapy
  • Combination Therapy

 

Market Breakup by Route of Administration

  • Oral
  • Tablets
  • Capsules
  • Parentals
  • Intravenous
  • Intramuscular
  • Topicals
  • Others

 

Plaque Psoriasis Treatment Market Breakup by Drug Type

  • Over the Counter
  • Prescription
  • Branded
  • Generics

 

Market Breakup by Population Type

  • Children
  • Adults
  • Male 
  • Female
  • Geriatrics
  • Male 
  • Female

 

Market Breakup by Treatment Channel

  • Public
  • Private

 

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others

 

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

 

Plaque Psoriasis Treatment Market Breakup by Region

  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others

 

Plaque Psoriasis Treatment Market- Therapeutic Landscape

The treatments currently available in the plaque psoriasis treatment market can only help in relieving and controlling the symptoms and do not guarantee complete cure from the disease. These treatments must be regularly followed to be effective. If the patient does not follow the regime regularly, then it might not help in managing the symptoms.

 

  • Biological Drugs- These drugs are given via a shot or through a vein in the arm. Biological drugs help in targeting some immune cells and restrict the proteins from causing further inflammation. While these drugs help in relieving the symptoms of plaque psoriasis, these can severely affect the capability of the immune system to fight infections. The most popular biological drugs used in the treatment market include Apremilast, Atanercept, Infliximab, Adalimumab, Ustekinumab, Secukinumab, Ixekizumab, Guselkumab, Tildrakizumab, and Certolizumab, among others.
  • Systemic Drugs- These drugs are preferred in the case of severe condition. Systemic drugs work throughout the body and calm the immune system. It also controls the growth of new skin cells, leading to reduced inflammation. The most prominent systemic drugs circulating in the market are Methotrexate, Soriatane, Otezla, Sotyktu, and Cyclosporin, among others. These drugs are quite effective, however, the consumption of these drugs can also cause severe side effects. Some side effects include higher risk of skin cancer, liver disorders, and aggressive thoughts and/or depression, among others.
  • Topical Drugs- If the patient is experiencing the initial stage of plaque psoriasis, with just a few patches, then the dermatologist might suggest some topical treatment. These prescription creams, gels, or ointments can be applied directly to the affected area for the prescribed period of time. These can include a combination of exfoliating treatments, with moisturising creams, to get rid of the dead skin and to keep the flaky skin at bay. The dermatologist suggests the treatment on the basis of the severity of the condition. They can either prescribe these drugs to be used individually or in combination. The most common topical drugs prescribed for this condition include Calcipotriene, Tazarotene, Calcineurin Inhibitors, Roflumilast, and Salicylic Acid, among others.
  • Phototherapy- Phototherapy, also known as light therapy, is also used to reduce the inflammation and slow down the production of new skin cells in psoriasis patients. This treatment is preferred for patients experiencing mild to severe symptoms, or if they have not responded to any other treatment method. In this method, the affected skin is treated with ultraviolet light, which can help reduce the inflammation and can even clear up the patches completely. The treatment is extremely beneficial but can even increase the risk of developing skin cancer amongst psoriasis patients.

 

While these treatments can help relieve the symptoms, it is always better to follow preventive measures to avoid worsening the condition further. The patients can practise a healthy diet and regular skin care regime to avoid further damage, along with regular consultation with their doctors.

 

plaque psoriasis treatment market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Plaque Psoriasis Treatment Market Scenario

The demand for the treatment market is rapidly rising with the rising number of cases across the globe. Changing lifestyles of people, along with the rising addiction to tobacco-based products, cigarettes, and alcohol, has increased their risk of suffering from this condition. Rising number of obese people is also contributing to the rising prevalence of the disease, especially in North America.

 

North America is leading the global market with a significant share. While in the developing region, the awareness about the condition is pretty low, developed regions are taking initiatives to boost the awareness about the condition. For instance, August is celebrated as Psoriasis Awareness Month in the United States every year. During this month, the government aims to provide support to those who are affected by this condition and spread awareness about the condition. Such initiatives are leading to higher people opting for diagnosis when they experience any symptom similar symptoms, which results in early detection and timely treatment.

 

Apart from North America, Europe is also witnessing higher growth due to the rising prevalence of the disease. In the Asia Pacific region, leading countries like Australia and India are also witnessing fast growth due to the rising awareness about the condition and its treatment, aided by government support. Such measures are significantly aiding the growth of the market.

 

Key Players in the Global Plaque Psoriasis Treatment Market

The major companies working on the drugs and treatment of the condition and investing in the clinical trials include the following:

  • Pfizer Inc.
  • Abbvie Inc.
  • Novartis AG
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH.
  • Merck & Co Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd. 
  • AstraZeneca
  • Ampio Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Novartis International AG
  • Sun Pharmaceuticals Industries Ltd.
  • Stiefel Laboratories
  • UCB S.A.
  • LEO Pharma
  • Cipla Inc.
  • Rowan Bioceuticals
  • Glenmark Pharmaceuticals
  • Win-Medicare Pvt. Ltd.
  • Sanofi S.A.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnosis Method
  • Treatment Type
  • Therapy Type
  • Route of Administration
  • Drug Type
  • Population Type
  • Treatment Channel
  • End User
  • Distribution Channel
  • Region
Breakup by Diagnosis Method
  • Blood Tests
  • Skin Prick Test
  • Patch Test
  • Biopsy
  • Others
Breakup by Treatment Type
  • Biologics Drugs
  • Systemic Drugs
  • Phototherapy
  • Topical Drugs
  • Others
Breakup by Therapy Type
  • Monotherapy
  • Combination Therapy
Breakup by Route of Administration
  • Oral
  • Parentals
  • Topicals
  • Others
Breakup by Drug Type
  • Over the Counter
  • Prescription
Breakup by Population Type
  • Children
  • Adults
  • Geriatrics
Breakup by Treatment Channel
  • Public
  • Private
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Abbvie Inc.
  • Novartis AG
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH.
  • Merck & Co Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Industries Ltd. 
  • AstraZeneca
  • Ampio Pharmaceuticals Inc.
  • Eli Lilly and Company
  • Novartis International AG
  • Sun Pharmaceuticals Industries Ltd.
  • Stiefel Laboratories
  • UCB S.A.
  • LEO Pharma
  • Cipla Inc.
  • Rowan Bioceuticals
  • Glenmark Pharmaceuticals
  • Win-Medicare Pvt. Ltd.
  • Sanofi S.A.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Plaque Psoriasis Diseases Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Plaque Psoriasis Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Plaque Psoriasis Epidemiology (2016-2031)
    5.3    Europe Plaque Psoriasis Epidemiology (2016-2031)
    5.4    Asia-Pacific Plaque Psoriasis Epidemiology (2016-2031)
    5.5    Latin America Plaque Psoriasis Epidemiology (2016-2031)
    5.6    Middle East & Africa Plaque Psoriasis Epidemiology (2016-2031)
6    Global Plaque Psoriasis Treatment Market Overview
    6.1    Global Plaque Psoriasis Treatment Market Historical Value (2017-2023) 
    6.2    Global Plaque Psoriasis Treatment Market Forecast Value (2024-2032)
7    Global Plaque Psoriasis Treatment Market Landscape
    7.1    Plaque Psoriasis Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
8    Plaque Psoriasis Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Plaque Psoriasis Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Plaque Psoriasis Treatment Market Segmentation
    11.1    Global Plaque Psoriasis Treatment Market by Diagnosis Method 
        11.1.1    Market Overview
        11.1.2    Blood Tests
        11.1.3    Skin Prick Test
        11.1.4    Patch Test
        11.1.5    Biopsy 
        11.1.6    Others
    11.2    Global Plaque Psoriasis Treatment Market by Treatment Type
        11.2.1    Market Overview
        11.2.2    Biologics Drugs
            11.2.2.1    Apremilast
            11.2.2.2    Atanercept
            11.2.2.3    Infliximab
            11.2.2.4    Adalimumab
            11.2.2.5    Ustekinumab
            11.2.2.6    Secukinumab
            11.2.2.7    Ixekizumab
            11.2.2.8    Guselkumab
            11.2.2.9    Tildrakizumab
            11.2.2.10    Certolizumab
            11.2.2.11    Others
        11.2.3    Systemic Drugs
            11.2.3.1    Methotrexate
            11.2.3.2    Soriatane
            11.2.3.3    Otezla
            11.2.3.4    Sotyktu
            11.2.3.5    Cyclosporin
            11.2.3.6    Others
        11.2.4    Phototherapy
            11.2.4.1    Ultraviolet B (UVB)
        11.2.5    Topical Drugs
            11.2.5.1    Calcipotriene
            11.2.5.2    Tazarotene
            11.2.5.3    Calcineurin inhibitors
            11.2.5.4    Roflumilast
            11.2.5.5    Salicylic acid
            11.2.5.6    Others
        11.2.6    Others
    11.3    Global Plaque Psoriasis Treatment Market by Therapy Type
        11.3.1    Market Overview
        11.3.2    Monotherapy
        11.3.3    Combination Therapy
    11.4    Global Plaque Psoriasis Treatment Market by Route of Administration
        11.4.1    Market Overview
        11.4.2    Oral
            11.4.2.1    Tablets
            11.4.2.2    Capsules
        11.4.3    Parentals
            11.4.3.1    Intravenous
            11.4.3.2    Intramuscular
        11.4.4    Topicals
        11.4.5    Others
    11.5    Global Plaque Psoriasis Treatment Market by Drug Type
        11.5.1    Market Overview
        11.5.2    Over the Counter
        11.5.3    Prescription
            11.5.3.1    Branded
            11.5.3.2    Generics
    11.6    Global Plaque Psoriasis Treatment Market by Population Type
        11.6.1    Market Overview
        11.6.2    Children
        11.6.3    Adults
            11.6.3.1    Male 
            11.6.3.2    Female
        11.6.4    Geriatrics
            11.6.4.1    Male 
            11.6.4.2    Female
    11.7    Global Plaque Psoriasis Treatment Market by Treatment Channel
        11.7.1    Market Overview
        11.7.2    Public
        11.7.3    Private
    11.8    Global Plaque Psoriasis Treatment Market by End User
        11.8.1    Market Overview
        11.8.2    Hospitals
        11.8.3    Specialty Clinics
        11.8.4    Homecare Settings
        11.8.5    Others
    11.9    Global Plaque Psoriasis Treatment Market by Distribution Channel
        11.9.1    Market Overview
        11.9.2    Hospital Pharmacy
        11.9.3    Retail Pharmacy
        11.9.4    Online Pharmacy
        11.9.5    Others
    11.10    Global Plaque Psoriasis Treatment Market by Region
        11.10.1    Market Overview
        11.10.2    North America
        11.10.3    Europe 
        11.10.4    Asia Pacific
        11.10.5    Latin America
        11.10.6    Middle East and Africa
12    North America Plaque Psoriasis Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Plaque Psoriasis Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Plaque Psoriasis Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Plaque Psoriasis Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Plaque Psoriasis Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Pfizer Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Abbvie Inc.
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Novartis AG
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Amgen Inc.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Boehringer Ingelheim International GmbH.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Merck & Co Inc.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Sun Pharmaceutical Industries Ltd.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Teva Pharmaceuticals Industries Ltd. 
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    AstraZeneca
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Ampio Pharmaceuticals Inc.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Eli Lilly and Company
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Novartis International AG
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Sun Pharmaceuticals Industries Ltd.
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    Stiefel Laboratories
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    UCB S.A.
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
    23.16    LEO Pharma
        23.16.1    Financial Analysis
        23.16.2    Product Portfolio
        23.16.3    Demographic Reach and Achievements
        23.16.4    Mergers and Acquisitions
        23.16.5    Certifications
    23.17    Cipla Inc.
        23.17.1    Financial Analysis
        23.17.2    Product Portfolio
        23.17.3    Demographic Reach and Achievements
        23.17.4    Mergers and Acquisitions
        23.17.5    Certifications
    23.18    Rowan Bioceuticals
        23.18.1    Financial Analysis
        23.18.2    Product Portfolio
        23.18.3    Demographic Reach and Achievements
        23.18.4    Mergers and Acquisitions
        23.18.5    Certifications
    23.19    Glenmark Pharmaceuticals
        23.19.1    Financial Analysis
        23.19.2    Product Portfolio
        23.19.3    Demographic Reach and Achievements
        23.19.4    Mergers and Acquisitions
        23.19.5    Certifications
    23.20    Win-Medicare Pvt. Ltd.
        23.20.1    Financial Analysis
        23.20.2    Product Portfolio
        23.20.3    Demographic Reach and Achievements
        23.20.4    Mergers and Acquisitions
        23.20.5    Certifications
    23.21    Sanofi S.A.
        23.21.1    Financial Analysis
        23.21.2    Product Portfolio
        23.21.3    Demographic Reach and Achievements
        23.21.4    Mergers and Acquisitions
        23.21.5    Certifications
24    Plaque Psoriasis Treatment Market- Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The number of plaque psoriasis cases was close to 128.64 million in 2023.

The prevalence of the condition is likely to grow at a CAGR of 3% during the forecast period of 2024-2032. The number of cases are likely to reach close to 167.84 million by 2032.

The growth of the market is driven by the rising prevalence of the disease, rising population of obese people, growing addiction to cigarettes and alcohol, and sun damage, among others.

The rising awareness about the condition, along with the readily available treatments, acts as key trends for the market.

The diagnosis methods can be categorised into blood tests, skin prick test, patch test, and biopsy, among others.

The condition is treated with biological drugs, systemic drugs, and topical drugs. Apart from drugs, phototherapy is also used to treat the patches.

The therapy types used for plaque psoriasis include monotherapy and combination therapy.

The routes of administration include oral, parentals, and topicals, among others.

The population type can be categorised into children, adults, and geriatrics.

The treatment channels in the market include private and public channels.

The end-user segments include hospitals, specialty clinics, and homecare settings, among others.

The distribution channels in the market include hospital pharmacy, retail pharmacy, and online pharmacy, among others.

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The key players in the market include Pfizer Inc., Abbvie Inc., Novartis AG, Amgen Inc., Boehringer Ingelheim International GmbH., Merck & Co Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca, Ampio Pharmaceuticals Inc., Eli Lilly and Company, Novartis International AG, Sun Pharmaceuticals Industries Ltd., Stiefel Laboratories, UCB S.A., LEO Pharma, Cipla Inc., Rowan Bioceuticals, Win-Medicare Pvt. Ltd., Sanofi S.A., and Glenmark Pharmaceuticals.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER